title: Acute stroke therapy: are we ready for primetime clinical trials?
authors.forename: Peter
authors.initials: P
authors.lastname: Kan
authors.forename: Travis M
authors.initials: TM
authors.lastname: Dumont
authors.forename: Elad I
authors.initials: EI
authors.lastname: Levy
authors.forename: Adnan H
authors.initials: AH
authors.lastname: Siddiqui
authors.forename: L Nelson
authors.initials: LN
authors.lastname: Hopkins
mesh_terms: D016893:Carotid Stenosis / Q000601:surgery; D002986:Clinical Trials as Topic / Q000639:trends*; D016894:Endarterectomy, Carotid; D057510:Endovascular Procedures; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D020521:Stroke / Q000628:therapy*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator